A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer
Conditions
- ER Positive, Her2 Negative Breast Cancer Patients
- Triple Negative Breast Cancer Patients
Interventions
- DRUG: MM-121
- DRUG: Paclitaxel
Sponsor
Merrimack Pharmaceuticals
Collaborators